Pharmalot By Ed Silverman Greece plans to go to court to seek compensation from Novartis over a bribery scandal
Pharmalot By Ed Silverman Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge
Color Code By Nicholas St. Fleur A ‘city on fire’: How Miami shaped a disputed diagnosis used to justify deaths in police custody
Biotech By Kate Sheridan When biotech acquisitions spike, early-stage startups are prime targets, analysis shows
Health By Carl Zimmer The surprising history of the war on superbugs — and what it means for the world today
Biotech By Damian Garde and Ed Silverman With superbug scourge looming, global group bets on biotechs to turn the tide
Signal Podcast By Meg Tirrell and Luke Timmerman Listen: Episode 13: The superbugs are winning the battle against us
Health By Helen Branswell Superbugs for dummies: Explaining the battle between bacteria and antibiotics